Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12286405
Scalable synthesis of dual-target inhibitor of cannabinoid-1 receptor and inducible nitric oxide synthase
granted -
US 12286483
Method of treating cancer using CD137 antibodies and PD-1 antagonists
granted -
US 12286630
Treatment methods for muscular dystrophy
granted -
US 12286402
Compounds and their use for the treatment of alpha1-antitrypsin deficiency
granted -
US 12286400
Isofagomine salts, methods of use and formulations
granted -
US 12286456
Purification of virus like particles
granted -
US 12285357
Intraocular drug delivery systems and methods of use
granted -
US 12286406
Inhibitors of receptor interacting protein kinase I for the treatment of disease
granted -
US 12285496
Gene therapy for haploinsufficiency
granted -
US 12286407
Estrogen receptor beta ligands for the prevention and treatment of multiple sclerosis (MS) and other demyelinating, inflammatory and neurodegenerative diseases
granted -
US 12285460
Pharmaceutical compositions
granted -
US 12285404
Prevention of rosacea inflammation
granted -
US 12285397
Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxylic acid and related compounds, (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and vigabatrin in the treatment of developmental disorders
granted -
US 12286395
Method of synthesis of an ionizable cationic lipid
granted -
US 12286480
Modulators of ROR1-ROR2 binding
granted -
US 2025129145
BI- AND MULTIVALENT ALBUMIN BINDERS
granted -
EP 4541380
STABILE KONZENTRIERTE RADIONUKLID-KOMPLEX-LÖSUNGEN
granted -
US 12280113
Ras inhibitors
granted -
US 12280063
Anti-retroviral therapies and reverse transcriptase inhibitors for treatment of Alzheimer's disease
granted -
US 12280122
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
granted -
US 12281073
Substituted piperidine compound and use thereof
granted -
US 12281327
Lymphohematopoietic engineering using CAS9 base editors
granted -
US 12281321
Frataxin expression constructs having engineered promoters and methods of use thereof
granted -
US 12281329
Compositions and methods for immune cell modulation in adoptive immunotherapies
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.